AQR Arbitrage’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

AQR Arbitrage’s Portfolio ICPT Stock Details ICPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-734,970	Closed	-$13.6M	–	815
2023 Q3	$13.6M	Buy	+734,970	New	+$8.31M	0.61%	47

AQR Arbitrage's ICPT Position: Q4 2023 in Review

AQR Arbitrage sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2023, closing a stake of 734,970 shares — an estimated $13.6M sold.

AQR Arbitrage first reported a position in ICPT in Q3 2023 and held it in 1 quarter. The position peaked at $13.6M in Q3 2023. 0 funds tracked by Wall St. Rank hold ICPT as of Q4 2023.

AQR Arbitrage reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2023 after selling out during the quarter.
AQR Arbitrage sold 734,970 Intercept Pharmaceuticals, Inc. shares in Q4 2023, an estimated $13.6M.
AQR Arbitrage first reported a position in Intercept Pharmaceuticals, Inc. in Q3 2023 and held it in 1 quarter.
AQR Arbitrage's Intercept Pharmaceuticals, Inc. position peaked at $13.6M in Q3 2023.
0 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2023.

Based on AQR Arbitrage's 13F filing for Q4 2023, filed 14 Feb 2024.